FindTrial
Sign In

Susceptibility of Intracardiac Thrombogenesis and Difference in Atrial Appendage of Atrial Fibrillation Patients

The Study of Susceptibility of Atrial Appendage Thrombogenesis in Atrial Fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058303
Enrollment
Unknown
Registered
2022-04-05
Start date
2022-01-31
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Sinus rhythm group:None
Paroxysmal atrial fibrillation group:None
Persistent atrial fibrillation group:None

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with persistent or permanent NON-valvular atrial fibrillation; 2. Without atrial fibrillation ablation; 3. Without coronary heart disease, heart failure and other cardiovascular diseases except atrial fibrillation; 4. Aged 40-70 years;

Exclusion criteria

Exclusion criteria: 1. Unwilling to sign informed consent and refuse to participate in clinical studies; 2. Tumor patients; 3. Previous maze surgery; 4. Severe heart, brain and respiratory diseases.

Design outcomes

Primary

MeasureTime frame
Ejection fraction;Markers of heart failure;Myocardial infarction marker -1;Myocardial infarction marker -2;RNA sequencing of heart tissue;—

Countries

China

Contacts

Public ContactYang Jie, Tan Hu

Second Affiliated Hospital of PLA Army Medical University

372534493@qq.com+86 1862330911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026